Climate Neutrality in the Biopharma Industry, How Do We Get There?

by Lynn Stephenson, PhD | October 13, 2023


The annual Lancet Countdown on health and climate change reported that the healthcare industry contributes ~5% of global greenhouse gas emissions with approximately half coming from healthcare supply chains.  According to Biopharma International, without rapid decarbonization, the industry is on track to triple those emissions by 2050.   Healthcare companies are acting to reduce their climate impact and they are looking to their suppliers to help them meet their climate goals. To address these challenges, suppliers to the healthcare industry need to become more green, more efficient, and more circular.

How do we get there?

For the Life Science industry, meeting these goals will require a transformation in strategy that embeds sustainability principles into business decisions. At

, we have set the ambitious goal to be climate neutral by 2040 and to leverage our expertise, experience, and partnerships to be a sustainability multiplier for our customers and collaborators.  In the first edition of the DCAT Sustainability eBook, Darren Verlenden, Head of Process Solutions and Ivan Donzelot, Head of Integrated Supply Chain, were recently featured in the first edition of the DCAT Sustainability eBook which focused on initiatives to improve sustainability in the Bio/Pharmaceutical supply chain.  They share examples of how we have operationalized sustainability into our business processes and how the alignment of business and supply chain goals, with the support of the Life Science Sustainability team, is one of the keys to the successes we are seeing with these efforts.

Want to learn more?

Download the DCAT eBook!


Related Posts

Video Interview: How to achieve a more robust supply chain

Watch Now Will your supply chain hold up to extreme weather? Pandemics? Civil unrest? Catastrophic events have led…

Can we change the Biopharma Supply Chain Game so that Everyone Gets a Trophy?

There is a popular board game based on a global disease outbreak that is generally rated 5 stars. ...

Coming Full Circle with Biopharma Recycling

This post discusses the environmental challenges posed by the Biopharmaceutical industry's heavy reliance on single-use systems and the...

Scroll to Top